Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M504750200 on August 28, 2005

J. Biol. Chem., Vol. 280, Issue 43, 36019-36028, October 28, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/43/36019    most recent
M504750200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reppel, M.
Right arrow Articles by Fleischmann, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reppel, M.
Right arrow Articles by Fleischmann, B. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

S100A1 Enhances the L-type Ca2+ Current in Embryonic Mouse and Neonatal Rat Ventricular Cardiomyocytes*

Michael Reppel{ddagger}1, Philipp Sasse{ddagger}§, Roland Piekorz¶, Ming Tang||, Wilhelm Roell**, Yaqi Duan{ddagger}, Anja Kletke¶, Jürgen Hescheler{ddagger}, Bernd Nürnberg¶, and Bernd K. Fleischmann§2

From the {ddagger}Institute of Neurophysiology, University of Cologne, Cologne 50931, Germany, §Institute of Physiology I and **Department of Cardiothoracic Surgery, University of Bonn, Bonn 53105, Germany, the Department of Biochemistry and Molecular Biology II, University of Düsseldorf, 40225 Düsseldorf, Germany, and the ||Department of Physiology, Tongji Medical College, Wuhan 4-30030, China

S100A1 is an EF-hand type Ca2+-binding protein with a muscle-specific expression pattern. The highest S100A1 protein levels are found in cardiomyocytes, and it is expressed already at day 8 in the heart during embryonic development. Since S100A1 is known to be involved in the regulation of Ca2+ homeostasis, we tested whether extracellular S100A1 plays a role in regulating the L-type Ca2+ current (ICa) in ventricular cardiomyocytes. Murine embryonic (day 16.5 postcoitum) ventricular cardiomyocytes were incubated with S100A1 (0.001–10 µM) for different time periods (20 min to 48 h). ICa density was found to be significantly increased as early as 20 min (from –10.8 ± 1 pA/pF, n = 18, to –22.9 ± 1.4 pA/pF; +112.5 ± 13%, n = 9, p < 0.001) after the addition of S100A1 (1 µM). S100A1 also enhanced ICa current density in neonatal rat cardiomyocytes. Fluorescence and capacitance measurements evidenced a fast translocation of rhodamine-coupled S100A1 from the extracellular space into cardiomyocytes. S100A1 treatment did not affect cAMP levels. However, protein kinase inhibitor, a blocker of cAMP-dependent protein kinase A (PKA), abolished the S100A1-induced enhancement of ICa. Accordingly, measurements of PKA activity yielded a significant increase in S100A1-treated cardiomyocytes. In vitro reconstitution assays further demonstrated that S100A1 enhanced PKA activity. We conclude that the Ca2+-binding protein S100A1 augments transsarcolemmal Ca2+ influx via an increase of PKA activity in ventricular cardiomyocytes and hence represents an important regulator of cardiac function.


Received for publication, April 29, 2005 , and in revised form, August 18, 2005.

* This study was supported by grants of the Deutsche Gesellschaft für Kardiologie (to M. R.) and by the Deutsche Forschungsgemeinschaft (to B. N. and R. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence may be addressed: Institute of Neurophysiology, University of Cologne, Robert-Koch-Str. 39, 50931 Cologne, Germany. Tel.: 49-478-6966; Fax: 49-221-3834; E-mail: michael.reppel{at}uni-koeln.de. 2 To whom correspondence may be addressed: Institute of Physiology I, Life & Brain Center, University of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany. Tel.: 49-228-6885-200; Fax: 49-228-6885-201; E-mail: bernd.fleischmann{at}uni-bonn.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement